Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic ProfilingGiuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Blood|December 4, 2019
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLLMarwan Kwok, Ceri Oldreive, Andy C Rawstron, et al.
Nature Genetics|December 3, 2013
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaHelen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, et al.
Nature Genetics|September 2, 2008
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMaria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, et al.
The British Journal of Radiology|June 10, 2025
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI studySam Keaveney, Damien J McHugh, Mihaela Rata, et al.
Nature Communications|January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemiaWei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Nature Genetics|August 20, 2013
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskDaniel Chubb, Niels Weinhold, Peter Broderick, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic ProfilingGiuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Blood|December 4, 2019
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLLMarwan Kwok, Ceri Oldreive, Andy C Rawstron, et al.
Nature Genetics|December 3, 2013
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaHelen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, et al.
Nature Genetics|September 2, 2008
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMaria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, et al.
The British Journal of Radiology|June 10, 2025
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI studySam Keaveney, Damien J McHugh, Mihaela Rata, et al.
Nature Communications|January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemiaWei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Nature Genetics|August 20, 2013
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskDaniel Chubb, Niels Weinhold, Peter Broderick, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Pageof 14